Editorial

. 2023 Feb 21;12(5):1709.

doi: 10.3390/jcm12051709.

Advances in Neurodegenerative Diseases

Jeroen Van Schependom^{1

2}, Miguel D'haeseleer^{1

3

4}

Affiliations

¹ Center for Neurosciences, NEUR and AIMS Research Groups, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussel, Belgium.
² Department of Electronics and Informatics (ETRO), Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium.
³ Department of Neurology, Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Brussels, Belgium.
⁴ Nationaal Multiple Sclerose Centrum, Vereeckenstraat 44, 1820 Melsbroek, Belgium.

PMID: 36902495
PMCID: PMC10002914
DOI: 10.3390/jcm12051709

Editorial

Advances in Neurodegenerative Diseases

Jeroen Van Schependom et al. J Clin Med. 2023.

. 2023 Feb 21;12(5):1709.

doi: 10.3390/jcm12051709.

Authors

Jeroen Van Schependom^{1

2}, Miguel D'haeseleer^{1

3

4}

Affiliations

¹ Center for Neurosciences, NEUR and AIMS Research Groups, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussel, Belgium.
² Department of Electronics and Informatics (ETRO), Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium.
³ Department of Neurology, Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Brussels, Belgium.
⁴ Nationaal Multiple Sclerose Centrum, Vereeckenstraat 44, 1820 Melsbroek, Belgium.

PMID: 36902495
PMCID: PMC10002914
DOI: 10.3390/jcm12051709

Abstract

Neurological disorders are the leading cause of physical and cognitive disability across the globe, currently affecting approximately 15% of the worldwide population [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Cited by

The effectiveness of telehealth interventions for people with multiple sclerosis: A systematic review and meta-analysis protocol.
Heidari-Soureshjani R, Daneshvar M, Mohammadi T, Negarandeh R, Sayadi L. Heidari-Soureshjani R, et al. Digit Health. 2023 Nov 27;9:20552076231216562. doi: 10.1177/20552076231216562. eCollection 2023 Jan-Dec. Digit Health. 2023. PMID: 38033519 Free PMC article.
Probing protein aggregation through spectroscopic insights and multimodal approaches: A comprehensive review for counteracting neurodegenerative disorders.
Bashir S, Aiman A, Chaudhary AA, Khan N, Ahanger IA, Sami N, Almugri EA, Ali MAM, Khan SU, Shahid M, Basir SF, Hassan MI, Islam A. Bashir S, et al. Heliyon. 2024 Mar 18;10(7):e27949. doi: 10.1016/j.heliyon.2024.e27949. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38689955 Free PMC article. Review.
Biomaterial strategies for regulating the neuroinflammatory response.
Galindo AN, Frey Rubio DA, Hettiaratchi MH. Galindo AN, et al. Mater Adv. 2024 Apr 10;5(10):4025-4054. doi: 10.1039/d3ma00736g. eCollection 2024 May 20. Mater Adv. 2024. PMID: 38774837 Free PMC article. Review.
Metabolic Endotoxemia: From the Gut to Neurodegeneration.
Chmielarz M, Sobieszczańska B, Środa-Pomianek K. Chmielarz M, et al. Int J Mol Sci. 2024 Jun 26;25(13):7006. doi: 10.3390/ijms25137006. Int J Mol Sci. 2024. PMID: 39000116 Free PMC article. Review.
Insights into the Role of microRNAs as Clinical Tools for Diagnosis, Prognosis, and as Therapeutic Targets in Alzheimer's Disease.
Puranik N, Song M. Puranik N, et al. Int J Mol Sci. 2024 Sep 14;25(18):9936. doi: 10.3390/ijms25189936. Int J Mol Sci. 2024. PMID: 39337429 Free PMC article. Review.

See all "Cited by" articles

References

1. Feigin V.L., Vos T., Nichols E., O Owolabi M., Carroll W.M., Dichgans M., Deuschl G., Parmar P., Brainin M., Murray C. The global burden of neurological disorders: Translating evidence into policy. Lancet Neurol. 2019;19:255–265. doi: 10.1016/S1474-4422(19)30411-9. - DOI - PMC - PubMed
1. Dorsey E.R., Glidden A.M., Holloway M.R., Birbeck G.L., Schwamm L.H. Teleneurology and mobile technologies: The future of neurological care. Nat. Rev. Neurol. 2018;14:285–297. doi: 10.1038/nrneurol.2018.31. - DOI - PubMed
1. Ivanova M.J.I., Birnbaum H.G., Samuels S., Davis M., Phillips A.L., Meletiche D. The Cost of Disability and Medically Related Absenteeism Among Employees with Multiple Sclerosis in the US. Pharmacoeconomics. 2009;27:681–691. doi: 10.2165/11314700-000000000-00000. - DOI - PubMed
1. Wong W. Economic burden of Alzheimer’s disease and managed care considerations. Am. J. Manag. Care. 2020;26((Suppl. 8)):S177–S183. - PubMed
1. Welch H.G., Walsh J.S., Larson E.B. The Cost of Institutional Care in Alzheimer’s Disease: Nursing Home and Hospital Use in a Prospective Cohort. J. Am. Geriatr. Soc. 1992;40:221–224. doi: 10.1111/j.1532-5415.1992.tb02072.x. - DOI - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Advances in Neurodegenerative Diseases

Affiliations

Advances in Neurodegenerative Diseases

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

Related information

LinkOut - more resources

Full Text Sources